2016
Two-Year Outcomes from a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction.
Polly DW, Swofford J, Whang PG, Frank CJ, Glaser JA, Limoni RP, Cher DJ, Wine KD, Sembrano JN. Two-Year Outcomes from a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction. The International Journal Of Spine Surgery 2016, 10: 28. PMID: 27652199, PMCID: PMC5027818, DOI: 10.14444/3028.Peer-Reviewed Original ResearchSubstantial clinical benefitNon-surgical treatmentSacroiliac joint dysfunctionTriangular titanium implantsClinical improvementMonth 24Clinical benefitSIJ painNSM groupSIJ dysfunctionJoint dysfunctionChronic low back painInvasive Sacroiliac Joint FusionChronic SIJ dysfunctionUnderwent revision surgeryNon-surgical managementTwo-Year OutcomesSacroiliac joint fusionLow back painProportion of subjectsQuality of lifeODI scoresSIJ fusionPain scoresSurgery group
2015
Superion® InterSpinous Spacer for treatment of moderate degenerative lumbar spinal stenosis: durable three-year results of a randomized controlled trial
Patel VV, Nunley PD, Whang PG, Haley TR, Bradley WD, Davis RP, Block JE, Geisler FH. Superion® InterSpinous Spacer for treatment of moderate degenerative lumbar spinal stenosis: durable three-year results of a randomized controlled trial. Journal Of Pain Research 2015, Volume 8: 657-662. PMID: 26491369, PMCID: PMC4599047, DOI: 10.2147/jpr.s92633.Peer-Reviewed Original ResearchDegenerative lumbar spinal stenosisLumbar spinal stenosisPrimary composite endpointSpinal stenosisComposite endpointClinical outcomesDrug Administration Investigational Device Exemption trialDisease-specific functional outcomesInvestigational device exemption trialDurable clinical improvementLeg pain severityRandomized study groupsZurich Claudication QuestionnaireProcedure-related complicationsIntermittent neurogenic claudicationTreatment of patientsProportion of subjectsThree-year resultsTreatment of subjectsIndividual patient successNeurogenic claudicationPrimary endpointClinical improvementCorresponding success ratesPain severity